Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Lymphoma

  Free Subscription


08.01.2018

2 BMC Cancer
1 Haematologica
1 Int J Cancer
3 Leuk Lymphoma
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. ZHOU J, Zheng J, Zhang X, Zhao J, et al
    Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment.
    BMC Cancer. 2018;18:10.
    PubMed     Text format     Abstract available

  2. SUN F, Zhu J, Lu S, Zhen Z, et al
    An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.
    BMC Cancer. 2018;18:5.
    PubMed     Text format     Abstract available


    Haematologica

  3. JI MM, Huang YH, Huang JY, Wang ZF, et al
    Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.
    Haematologica. 2018 Jan 5. pii: haematol.2017.182444.
    PubMed     Text format     Abstract available


    Int J Cancer

  4. JANKET SJ, Ackerson LK, Meurman JH
    Potential reverse causation?
    Int J Cancer. 2017;140:2168.
    PubMed     Text format    


    Leuk Lymphoma

  5. DITTUS C, Grover N, Ellsworth S, Tan X, et al
    Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis.
    Leuk Lymphoma. 2018 Jan 5:1-7. doi: 10.1080/10428194.2017.1416365.
    PubMed     Text format     Abstract available

  6. CRAMER P, Fraser G, Santucci-Silva R, Grosicki S, et al
    Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in t
    Leuk Lymphoma. 2018 Jan 3:1-10. doi: 10.1080/10428194.2017.1416364.
    PubMed     Text format     Abstract available

  7. WEVER CM, Geoffrion D, Grande BM, Yu S, et al
    The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.
    Leuk Lymphoma. 2018 Jan 3:1-16. doi: 10.1080/10428194.2017.1413186.
    PubMed     Text format     Abstract available


    PLoS One

  8. BYFORD ET, Carr M, Ladikou E, Ahearne MJ, et al
    Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma.
    PLoS One. 2018;13:e0190468.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  9. LU L, Zhu F, Zhang M, Li Y, et al
    Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma.
    Proc Natl Acad Sci U S A. 2018 Jan 2. pii: 1715118115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: